By Michael Burger, EDI and EHR Practice Lead
The Time is Right for Canada to Incorporate a Naming Convention for Biologics and Biosimilars into its Emerging ePrescribing Infrastructure
By Pooja Babbrah, Senior Consultant
Drug Price Transparency: Drivers at the Point of Prescribing
By Tony Schueth, CEO and Managing Partner
EHR Vendors: Are You Ready for Standards Changes Coming Soon to ePrescribing?
By Michael Burger, EHR and EDI Practice Lead
State and Federal Regulations Continue to Target the Opioid Epidemic and Part D Prescribing
By Keith Fisher, R.Ph. and Michelle Soble, R.Ph. Co-Leads, POCP Regulatory Resource Center
New NCPDP Specialty Pharmacy Workgroup to Meet on August 3
By Pooja Babbrah, Practice Lead, PBM Services
Should Data Sharing and Interoperability be Linked to Medicare Participation?
By Michael Burger, Practice Lead, EHRs and EDI
Opioid Management and Electronic Prior Authorization Among Key State and Federal Legislative Initiatives
By Keith Fisher, R.Ph. Co-lead of the Regulatory Resource Center
Medicare Announces New Requirements Affecting EHRs
<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;"...
Part 2: Combining Health Insurers and Pharmacy Benefit Managers: Bringing Down the Information Silos
By Michael Solomon, PhD, MBA, Practice Lead, eCare Management
